Hantech Bio-Technology Co., Ltd.
Hantech Bio-Technology Co., Ltd. manufactures and sells health supplement products in Taiwan. It provides dietary supplements in gel, liquid, and powder forms under OEM or ODM partnerships. The company offers its dietary supplements in various packages, such as rectangle, curve, Z, round, wine bottle, and standing pouches. Hantech Bio-Technology Co., Ltd. was founded in 2007 and is headquartered … Read more
Hantech Bio-Technology Co., Ltd. (1294) - Net Assets
Latest net assets as of : NT$- TWD
Based on the latest financial reports, Hantech Bio-Technology Co., Ltd. (1294) has net assets worth NT$- TWD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$-) and total liabilities (NT$-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Hantech Bio-Technology Co., Ltd. - Net Assets Trend (None–None)
This chart illustrates how Hantech Bio-Technology Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hantech Bio-Technology Co., Ltd. (None–None)
The table below shows the annual net assets of Hantech Bio-Technology Co., Ltd. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Hantech Bio-Technology Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Hantech Bio-Technology Co., Ltd. Competitors by Market Cap
The table below lists competitors of Hantech Bio-Technology Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Healthcare Integrated Technologies Inc
PINK:HITC
|
$33.88 Million |
|
Q32 Bio Inc
NASDAQ:QTTB
|
$33.88 Million |
|
Metal Sky Star Acquisition Corporation Ordinary shares
NASDAQ:MSSA
|
$33.90 Million |
|
Novacyt S.A
PINK:NVYTF
|
$33.90 Million |
|
HeXun Biosciences Co., Ltd.
TWO:6986
|
$33.87 Million |
|
Articore Group Ltd
AU:ATG
|
$33.87 Million |
|
Metacon AB
ST:META
|
$33.87 Million |
|
THINKWARE Corporation
KQ:084730
|
$33.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hantech Bio-Technology Co., Ltd.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Hantech Bio-Technology Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Hantech Bio-Technology Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Hantech Bio-Technology Co., Ltd.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $17,559,023,800
- Average return on equity (ROE) among peers: 8.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hantech Bio-Technology Co., Ltd. (1294) | NT$- | N/A | N/A | $33.88 Million |
| Wei Chuan Foods Corp (1201) | $5.55 Billion | 12.34% | 1.69x | $125.16 Million |
| Ve Wong Corp (1203) | $6.25 Billion | 7.16% | 0.53x | $76.18 Million |
| Great Wall Enterprise Co Ltd (1210) | $7.57 Billion | 10.72% | 1.28x | $893.11 Million |
| Charoen Pokphand Enterprise Taiwan Co Ltd (1215) | $5.36 Billion | 14.61% | 0.75x | $839.68 Million |
| Uni-President Enterprises Corp (1216) | $130.79 Billion | 9.49% | 1.59x | $10.01 Billion |
| AGV Products Corp (1217) | $6.27 Billion | 0.76% | 1.01x | $116.99 Million |
| Taisun Enterprise Co Ltd (1218) | $3.67 Billion | 6.42% | 1.09x | $108.34 Million |
| Fwusow Industry Co Ltd (1219) | $3.96 Billion | 5.13% | 1.26x | $99.99 Million |
| Tai Roun Products Co Ltd (1220) | $2.53 Billion | 5.26% | 0.26x | $37.61 Million |
| Formosa Oilseed Processing Co Ltd (1225) | $3.65 Billion | 9.29% | 1.12x | $49.69 Million |